- Home
- WSBC vs KYMR Comparison
WSBC vs KYMR Comparison
Compare WSBC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- KYMR
- Stock Information
- Founded
- WSBC 1870
- KYMR 2015
- Country
- WSBC United States
- KYMR United States
- Employees
- WSBC N/A
- KYMR N/A
- Industry
- WSBC Major Banks
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- WSBC Finance
- KYMR Health Care
- Exchange
- WSBC Nasdaq
- KYMR Nasdaq
- Market Cap
- WSBC 2.6B
- KYMR 2.2B
- IPO Year
- WSBC N/A
- KYMR 2020
- Fundamental
- Price
- WSBC $28.30
- KYMR $25.97
- Analyst Decision
- WSBC Buy
- KYMR Buy
- Analyst Count
- WSBC 5
- KYMR 13
- Target Price
- WSBC $40.20
- KYMR $56.69
- AVG Volume (30 Days)
- WSBC 827.3K
- KYMR 847.3K
- Earning Date
- WSBC 04-29-2025
- KYMR 05-01-2025
- Dividend Yield
- WSBC 5.22%
- KYMR N/A
- EPS Growth
- WSBC N/A
- KYMR N/A
- EPS
- WSBC 2.26
- KYMR N/A
- Revenue
- WSBC $586,985,000.00
- KYMR $47,072,000.00
- Revenue This Year
- WSBC $45.19
- KYMR $16.24
- Revenue Next Year
- WSBC $11.71
- KYMR $22.41
- P/E Ratio
- WSBC $12.53
- KYMR N/A
- Revenue Growth
- WSBC 0.50
- KYMR N/A
- 52 Week Low
- WSBC $25.56
- KYMR $19.45
- 52 Week High
- WSBC $37.36
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- WSBC 40.57
- KYMR 44.70
- Support Level
- WSBC $26.42
- KYMR $24.43
- Resistance Level
- WSBC $29.50
- KYMR $26.06
- Average True Range (ATR)
- WSBC 1.35
- KYMR 2.36
- MACD
- WSBC 0.04
- KYMR 0.41
- Stochastic Oscillator
- WSBC 36.29
- KYMR 70.12
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.